Article
Circulating tumor DNA moves further into the spotlight
28 May 2014
Abstract excerpt
Assessment of somatic genomic alterations from tumors can now be performed by sequencing circulating tumor DNA from the cell-free component of blood. This procedure, which identifies tumor-derived somatic mutations from a simple blood sample, circumvents the need for tumor tissue. A recent study highlights the promise of circulating tumor DNA to guide therapeutic decisions in a variety of solid tumors for both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
